Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX [NA]

View source ↗

Summary

This trial compared tacrolimus plus mycophenolate mofetil to tacrolimus plus methotrexate for GVHD prophylaxis. It completed and posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Mucositis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Mucositis, Graft-versus-host Disease | NA | Status: COMPLETED | Results posted: 2013-05-03